222 related articles for article (PubMed ID: 20007976)
1. Liver X receptor agonists augment human islet function through activation of anaplerotic pathways and glycerolipid/free fatty acid cycling.
Ogihara T; Chuang JC; Vestermark GL; Garmey JC; Ketchum RJ; Huang X; Brayman KL; Thorner MO; Repa JJ; Mirmira RG; Evans-Molina C
J Biol Chem; 2010 Feb; 285(8):5392-404. PubMed ID: 20007976
[TBL] [Abstract][Full Text] [Related]
2. The synthetic liver X receptor agonist GW3965 reduces tissue factor production and inflammatory responses in human islets in vitro.
Scholz H; Lund T; Dahle MK; Collins JL; Korsgren O; Wang JE; Foss A
Diabetologia; 2009 Jul; 52(7):1352-62. PubMed ID: 19415233
[TBL] [Abstract][Full Text] [Related]
3. Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines.
Meng ZX; Yin Y; Lv JH; Sha M; Lin Y; Gao L; Zhu YX; Sun YJ; Han X
Diabetologia; 2012 Jun; 55(6):1733-44. PubMed ID: 22415588
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity.
Kim KH; Lee GY; Kim JI; Ham M; Won Lee J; Kim JB
J Lipid Res; 2010 Dec; 51(12):3425-33. PubMed ID: 20847297
[TBL] [Abstract][Full Text] [Related]
5. Sterol regulatory element-binding protein 1 mediates liver X receptor-beta-induced increases in insulin secretion and insulin messenger ribonucleic acid levels.
Zitzer H; Wente W; Brenner MB; Sewing S; Buschard K; Gromada J; Efanov AM
Endocrinology; 2006 Aug; 147(8):3898-905. PubMed ID: 16644917
[TBL] [Abstract][Full Text] [Related]
6. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
[TBL] [Abstract][Full Text] [Related]
7. Fetal liver X receptor activation acutely induces lipogenesis but does not affect plasma lipid response to a high-fat diet in adult mice.
van Straten EM; van Meer H; Huijkman NC; van Dijk TH; Baller JF; Verkade HJ; Kuipers F; Plösch T
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1171-8. PubMed ID: 19724022
[TBL] [Abstract][Full Text] [Related]
8. Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1.
Briand O; Touche V; Colin S; Brufau G; Davalos A; Schonewille M; Bovenga F; Carrière V; de Boer JF; Dugardin C; Riveau B; Clavey V; Tailleux A; Moschetta A; Lasunción MA; Groen AK; Staels B; Lestavel S
Gastroenterology; 2016 Mar; 150(3):650-8. PubMed ID: 26602218
[TBL] [Abstract][Full Text] [Related]
9. Liver X receptor activation inhibits SGLT2-mediated glucose transport in human renal proximal tubular cells.
Chonlaket P; Wongwan T; Soodvilai S
Exp Physiol; 2018 Feb; 103(2):250-260. PubMed ID: 29127736
[TBL] [Abstract][Full Text] [Related]
10. A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARα.
Ducheix S; Podechard N; Lasserre F; Polizzi A; Pommier A; Murzilli S; Di Lisio C; D'Amore S; Bertrand-Michel J; Montagner A; Pineau T; Loiseau N; Lobaccaro JM; Martin PG; Guillou H
Biochimie; 2013 Mar; 95(3):556-67. PubMed ID: 23063693
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of Hedgehog signaling by liver X receptors.
Kim WK; Meliton V; Park KW; Hong C; Tontonoz P; Niewiadomski P; Waschek JA; Tetradis S; Parhami F
Mol Endocrinol; 2009 Oct; 23(10):1532-43. PubMed ID: 19608643
[TBL] [Abstract][Full Text] [Related]
12. Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover.
Green CD; Jump DB; Olson LK
Endocrinology; 2009 Jun; 150(6):2637-45. PubMed ID: 19228891
[TBL] [Abstract][Full Text] [Related]
13. Liver X receptor activation inhibits osteoclastogenesis by suppressing NF-κB activity and c-Fos induction and prevents inflammatory bone loss in mice.
Kim HJ; Yoon KA; Yoon HJ; Hong JM; Lee MJ; Lee IK; Kim SY
J Leukoc Biol; 2013 Jul; 94(1):99-107. PubMed ID: 23657115
[TBL] [Abstract][Full Text] [Related]
14. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
Blaschke F; Takata Y; Caglayan E; Collins A; Tontonoz P; Hsueh WA; Tangirala RK
Circ Res; 2006 Dec; 99(12):e88-99. PubMed ID: 17110595
[TBL] [Abstract][Full Text] [Related]
15. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms.
Morello F; Saglio E; Noghero A; Schiavone D; Williams TA; Verhovez A; Bussolino F; Veglio F; Mulatero P
Atherosclerosis; 2009 Nov; 207(1):38-44. PubMed ID: 19426978
[TBL] [Abstract][Full Text] [Related]
16. Liver X receptor activation downregulates organic anion transporter 1 (OAT1) in the renal proximal tubule.
Kittayaruksakul S; Soodvilai S; Asavapanumas N; Muanprasat C; Chatsudthipong V
Am J Physiol Renal Physiol; 2012 Mar; 302(5):F552-60. PubMed ID: 22169006
[TBL] [Abstract][Full Text] [Related]
17. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
Ishibashi M; Filomenko R; Rébé C; Chevriaux A; Varin A; Derangère V; Bessède G; Gambert P; Lagrost L; Masson D
Biochem Pharmacol; 2013 Jul; 86(1):122-9. PubMed ID: 23313547
[TBL] [Abstract][Full Text] [Related]
18. Liver X receptor agonists decrease ENaC-mediated sodium transport in collecting duct cells.
Soodvilai S; Jia Z; Fongsupa S; Chatsudthipong V; Yang T
Am J Physiol Renal Physiol; 2012 Dec; 303(12):F1610-6. PubMed ID: 23077096
[TBL] [Abstract][Full Text] [Related]
19. Lxr regulates lipid metabolic and visual perception pathways during zebrafish development.
Pinto CL; Kalasekar SM; McCollum CW; Riu A; Jonsson P; Lopez J; Swindell EC; Bouhlatouf A; Balaguer P; Bondesson M; Gustafsson JÅ
Mol Cell Endocrinol; 2016 Jan; 419():29-43. PubMed ID: 26427652
[TBL] [Abstract][Full Text] [Related]
20. Cilostazol inhibits insulin-stimulated expression of sterol regulatory binding protein-1c via inhibition of LXR and Sp1.
Jung YA; Kim HK; Bae KH; Seo HY; Kim HS; Jang BK; Jung GS; Lee IK; Kim MK; Park KG
Exp Mol Med; 2014 Jan; 46(1):e73. PubMed ID: 24458133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
